uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Vazkepa
Authorised
Human
Details
EMA number
EMEA/H/C/005398
ATC code
C10AX
Authorisation
26 March 2021
Revision
9
EMA page
Therapeutic indication
Indicated to reduce cardiovascular risk as an adjunct to statin therapy.
MeSH:
Dyslipidemias
Group:
Lipid modifying agents
Special characteristics
Additional monitoring
Active substances
Icosapent ethyl
Marketing Authorisation Holder
Recordati Industria Chimica e Farmaceutica S.p.A.
MAH
Timeline
Filter by authority:
EMA
Vazkepa authorised
26 Mar 2021
authorised
regulatory
Vazkepa | uMedical